FDA Inspection 1019810 — CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services

CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services — FEI 1672092

The FDA completed an inspection of CHI Health Systems Baylor St. Luke's Medical Center Transfusion Services on March 15, 2017 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 15, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)